224 related articles for article (PubMed ID: 6836968)
21. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
22. [Characteristics of cellular immunity in the surgical treatment of precancerous and malignant stomach diseases].
Kukosh VI; Efimov AV; Stikhanovskaia LD
Vestn Khir Im I I Grek; 1980 Jun; 124(6):37-40. PubMed ID: 6968112
[TBL] [Abstract][Full Text] [Related]
23. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
Shenouda G; Thomson DM; MacFarlane JK
Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
[TBL] [Abstract][Full Text] [Related]
24. [Study on organ antigens in the gastric mucosa, stomach cancer and its metastases].
Mamiliaeva ZKh
Vopr Onkol; 1977; 23(4):66-8. PubMed ID: 883198
[TBL] [Abstract][Full Text] [Related]
25. [State of blood basophilic granulocytes in the estimation of sensitization of patients with stomach neoplasm].
Gracheva ZA; Babakova SV; Gorodilova VV; Sokolova II
Vopr Onkol; 1976; 22(10):19-21. PubMed ID: 1014488
[TBL] [Abstract][Full Text] [Related]
26. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
Novikov DK; Borisenko ID; Shein IA
Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
[TBL] [Abstract][Full Text] [Related]
27. A modified leucocyte migration assay as indicator of malignant and non-malignant gastric mucosal alteration.
Zöller M; Matzku S; Rapp W; Schulz U
Digestion; 1977; 15(5):373-84. PubMed ID: 892259
[TBL] [Abstract][Full Text] [Related]
28. [Study of humoral and cellular immunity in normal subjects and in patients with gastric cancer, gastric ulcer an chronic gastritis].
Dávila M; Silva M; Rufin F; Ruíz F; Ugarte JM; Díaz H
Rev Med Chil; 1974 May; 102(5):353-8. PubMed ID: 4471398
[No Abstract] [Full Text] [Related]
29. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
30. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
31. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer].
Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh
Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698
[TBL] [Abstract][Full Text] [Related]
32. [Specificity of lymphocytic reaction to tumor antigens--approaches to a cancer diagnosis in vitro?].
Muhrer KH
Fortschr Med; 1984 Jan; 102(3):45-8. PubMed ID: 6199270
[TBL] [Abstract][Full Text] [Related]
33. [The quantitative determination of peripheral blood natural killers in stomach cancer patients].
Podil'chak MD; Teretskaia LM; Krasivskiĭ EZ
Vopr Onkol; 1990; 36(7):870-2. PubMed ID: 2399671
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
[TBL] [Abstract][Full Text] [Related]
35. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation.
Prinz C; Schöniger M; Rad R; Becker I; Keiditsch E; Wagenpfeil S; Classen M; Rösch T; Schepp W; Gerhard M
Cancer Res; 2001 Mar; 61(5):1903-9. PubMed ID: 11280745
[TBL] [Abstract][Full Text] [Related]
36. [Determination of the state of antitumor immunity and of serum blocking action in stomach cancer by using the leukocyte adherence inhibition reaction].
Grishchenko AM; Grinevich IuA; Alferov AN; Redkousova SF; Sen'ko LN
Vrach Delo; 1978 Aug; (8):28-32. PubMed ID: 695500
[No Abstract] [Full Text] [Related]
37. Cell-mediated cytotoxicity of mononuclear cells isolated from cancer and normal mucosa of the stomach.
Sakai Y; Koizumi K
Gastroenterology; 1982 Jun; 82(6):1374-80. PubMed ID: 7067957
[TBL] [Abstract][Full Text] [Related]
38. [Status of T-system immunity in patients with chronic diseases and cancer of the gastrointestinal tract].
Movsesian KS; Voĭtenkov BO; Mel'nikov RA; Evtiukhin AI; Stefanenko IuF
Vopr Onkol; 1985; 31(1):60-3. PubMed ID: 3871990
[TBL] [Abstract][Full Text] [Related]
39. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
40. Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy.
Bhatti RA; Ablin RJ; Guinan PD
J Reticuloendothel Soc; 1979 Apr; 25(4):389-95. PubMed ID: 458777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
